Guerbet LLC

Innocoll Biotherapeutics N.A. Inc. is a healthcare company based in Princeton, NJ, dedicated to delivering innovative solutions that improve the lives of patients. With a strong emphasis on collaboration and integrity, they work closely with hospitals and doctors to address post-surgical pain management challenges and elevate patient care. Driven by a passionate team of professionals, including their Chief Executive Officer, Chief Medical Officer, Chief Commercial Officer, and other key leaders, Innocoll Biotherapeutics N.A. Inc. is committed to reshaping healthcare through their core values of integrity, inclusion, collaboration, urgency, and accountability.Generated from the website

Y-mAbs Therapeutics, Inc is a clinical biopharmaceutical company based in New York, NY, specializing in the development and commercialization of antibody-based therapeutic products for the treatment of cancer. With a focus on addressing unmet medical needs in both pediatric and adult populations, Y-mAbs aims to become a global leader in the field of oncology. Through partnerships and collaborations, the company is dedicated to changing the course of cancer care and improving patient outcomes. Y-mAbs Therapeutics has a diverse and advanced product pipeline, including pivotal-stage candidates targeting various cancer types such as neuroblastoma, central nervous system leptomeningeal metastases, osteosarcoma, diffuse intrinsic pontine glioma, and medulloblastoma. The company's research and development efforts are centered around innovative platforms, including immunotherapy, radioimmunotherapy, and companion diagnostics. Founded by a father whose daughter survived high-risk neuroblastoma, Y-mAbs is committed to providing support to patients and their families, while continuously striving to develop effective antibody immunotherapies through ongoing clinical trials.Generated from the website

Azurity Pharmaceuticals, Inc. is a pharmaceutical company based in Woburn, Massachusetts. They specialize in developing innovative and high-quality medicines to serve patients with unmet needs in various therapeutic areas, including cardiovascular, central nervous system, endocrine, gastro-intestinal, anti-infective, and oncology. Azurity's dose-form innovations have benefited millions of people, providing them with effective treatment options. Recently, Azurity Pharmaceuticals acquired Slayback Pharma LLC, further expanding their portfolio of products. They are committed to providing patients with safe and effective medications, and their dedication to serving overlooked patients sets them apart in the pharmaceutical industry.Generated from the website